International Symposium on Ambulatory Medication Safety: Addressing Challenges to Knowledge Generation and Implementation
OVERVIEW
This invitation-only symposium is designed to provide a highly interactive exchange among selected medication safety leaders whose expertise spans pharmacoepidemiology, health services research, behavioural science, health policy and clinical medicine. The symposium will use concise overviews of key domains of ambulatory drug safety to engage participants regarding areas of greatest unmet need and opportunities for innovation. The event will include a total of 40-50 diverse participants representing several European countries as well as the United States and Canada. Varied presentation formats, as well as ample time for small group discussion and networking, will maximize scientific exchange and value.
AGENDA
Wednesday, June 21, 2023
8:00 AM – 5:00 PM
Arrival
Thursday, June 22, 2023
8:30 – 9:00 AM
Breakfast
9:00 - 9:30 AM
Introductory Comments
9:30 - 10:30 AM
Session 1: Optimizing Observational Research on Benefits and Harms
10:30 – 11:00 AM
Break
11:00 – 12:30 PM
Session 2: Leveraging Risk Prediction to Individualize Treatments
12:30 – 1:30 PM
Lunch
1:30 – 3:00 PM
Session 3: Quantifying and Communicating Cumulative Drug Risks
3:00 – 3:30 PM
Break
3:30 – 5:00 PM
Session 4: Harnessing Data to Improve Ambulatory Medication Safety
6:30 PM
Dinner
Friday, June 23, 2023
8:30 – 9:00 AM
Breakfast
9:30 - 10:30 AM
Session 5: Maximizing Medication Safety Through Interprofessional Collaboration
10:30 – 11:00 AM
Break
11:00 – 12:30 PM
Session 6: Designing and Evaluating Complex Interventions to Improve Drug Safety
12:30 – 13:00 PM
Closing Remarks
KEY NOTE SPEAKER
Sebastian Schneeweiss, Professor of Medicine and Epidemiology, Harvard Medical School
Sebastian Schneeweiss is Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine, Brigham and Women’s Hospital, a world-leading research and training center. His research is funded by multiple NIH, PCORI, and FDA grants and focuses on the comparative effectiveness and safety of biopharmaceuticals. He has developed analytic methods to improve the scientific validity of epidemiologic analyses using complex longitudinal healthcare databases particularly for newly marketed medical products. Applying such methods in rapid analysis cycles for sequential medication effectiveness monitoring and rapid response analyses is the overarching theme of his research. His work is published in >500 articles (H 93). He is Aetion Inc.’s co-founder and Science Lead were he develops a range of rapid-cycle analytics platforms for healthcare database networks around the world. Dr. Schneeweiss is PI of the Sentinel Innovation Center funded by FDA/CDER where he is a voting consultant to the FDA Drug Safety and Risk Management Advisory Committee. He was an inaugural member of the Methods Committee of the Patient-Centered Outcomes Research Institute. He is Past President of the International Society for Pharmacoepidemiology and is Fellow of the American College of Epidemiology, the American College of Clinical Pharmacology, and the International Society for Pharmacoepidemiology. He teaches courses at Harvard on Database Analytics for Pharmacoepidemiology and on Effectiveness Research in Longitudinal Healthcare Databases among others. He received his medical training at the University of Munich Medical School and his doctoral degree in pharmacoepidemiology from Harvard.
CONTACT
Tobias Dreischulte, PhD, MSc
80336 Munich
Caleb Alexander, MD, MS
80336 Munich
Beginn
22.06.2023, 08:30
Ende
23.06.2023, 12:30
Ort
Friedrich-von-Gärtner-Hörsaal, Institute for General Practice and Family Medicine, LMU Munich, Germany
Veranstalter
Tobias Dreischulte, Caleb Alexander; (Institute for General Practice and Family Medicine, LMU Munich, Germany)
Anmeldung unter
This is an invitation-only event.